Literature DB >> 23546811

A Large Intragenic Deletion in the ACADM Gene Can Cause MCAD Deficiency but is not Detected on Routine Sequencing.

Claire Searle1, Brage Storstein Andresen, Ed Wraith, Jamie Higgs, Deborah Gray, Alison Mills, K Elizabeth Allen, Emma Hobson.   

Abstract

We report of a family who has three members affected by medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, one of whom sadly died in the neonatal period prior to diagnosis. Routine sequencing, available on a service basis in the UK, identified only a heterozygous mutation in ACADM gene (c.985A>G, p.Lys329Glu) in this family. Linkage analysis suggested a possible intragenic deletion which was confirmed by the use of array-based comparative genomic hybridization (aCGH). This second mutation was a large intragenic deletion encompassing at least exons 1-6 of the ACADM gene. Now that this deletion has been identified, several family members have come forward for carrier testing which was not possible previously. Larger deletions (20bp or more) have only previously been reported twice, but these may be a more frequent cause of MCAD deficiency than hitherto believed, due to fact that these are not anticipated and, therefore, the routine diagnostic techniques used will not identify them. This finding represents a useful learning point in the management of families with MCAD deficiency, and highlights that we should be routinely looking for larger deletions, when only one of the mutations can be identified on standard sequencing.

Entities:  

Year:  2013        PMID: 23546811      PMCID: PMC3755559          DOI: 10.1007/8904_2013_216

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  8 in total

1.  Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  Esther M Maier; Bernhard Liebl; Wulf Röschinger; Uta Nennstiel-Ratzel; Ralph Fingerhut; Bernhard Olgemöller; Ulrich Busch; Nils Krone; Rüdiger v Kries; Adelbert A Roscher
Journal:  Hum Mutat       Date:  2005-05       Impact factor: 4.878

2.  Medium chain acyl-CoA dehydrogenase deficiency caused by a deletion of exons 11 and 12.

Authors:  A A Morris; R W Taylor; R N Lightowlers; A Aynsley-Green; K Bartlett; D M Turnbull
Journal:  Hum Mol Genet       Date:  1995-04       Impact factor: 6.150

3.  MCAD deficiency in Denmark.

Authors:  Brage Storstein Andresen; Allan Meldgaard Lund; David Michael Hougaard; Ernst Christensen; Birthe Gahrn; Mette Christensen; Peter Bross; Anne Vested; Henrik Simonsen; Kristin Skogstrand; Simon Olpin; Niels Jacob Brandt; Flemming Skovby; Bent Nørgaard-Pedersen; Niels Gregersen
Journal:  Mol Genet Metab       Date:  2012-04-04       Impact factor: 4.797

4.  Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency.

Authors:  B S Andresen; S F Dobrowolski; L O'Reilly; J Muenzer; S E McCandless; D M Frazier; S Udvari; P Bross; I Knudsen; R Banas; D H Chace; P Engel; E W Naylor; N Gregersen
Journal:  Am J Hum Genet       Date:  2001-05-08       Impact factor: 11.025

5.  A rare disease-associated mutation in the medium-chain acyl-CoA dehydrogenase (MCAD) gene changes a conserved arginine, previously shown to be functionally essential in short-chain acyl-CoA dehydrogenase (SCAD).

Authors:  B S Andresen; P Bross; T G Jensen; V Winter; I Knudsen; S Kølvraa; U B Jensen; L Bolund; M Duran; J J Kim
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

Review 6.  Interstitial deletion of 1p22.2p31.1 and medium-chain acyl-CoA dehydrogenase deficiency in a patient with global developmental delay.

Authors:  Gustavo H B Maegawa; Nicola K Poplawski; Brage Storstein Andresen; Simon E Olpin; Gloria Nie; Joe T R Clarke; Ikuko Teshima
Journal:  Am J Med Genet A       Date:  2008-06-15       Impact factor: 2.802

7.  Lack of genotype-phenotype correlations and outcome in MCAD deficiency diagnosed by newborn screening in New York State.

Authors:  Georgianne L Arnold; Carlos A Saavedra-Matiz; Patricia A Galvin-Parton; Richard Erbe; Ellen Devincentis; David Kronn; Shideh Mofidi; Melissa Wasserstein; Joan E Pellegrino; Paul A Levy; Darius J Adams; Matthew Nichols; Michele Caggana
Journal:  Mol Genet Metab       Date:  2009-11-01       Impact factor: 4.797

8.  The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario.

Authors:  Shelley Kennedy; Beth K Potter; Kumanan Wilson; Lawrence Fisher; Michael Geraghty; Jennifer Milburn; Pranesh Chakraborty
Journal:  BMC Pediatr       Date:  2010-11-17       Impact factor: 2.125

  8 in total
  1 in total

1.  Recurrent Ventricular Tachycardia in Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency.

Authors:  P Bala; S Ferdinandusse; S E Olpin; P Chetcuti; A A M Morris
Journal:  JIMD Rep       Date:  2015-09-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.